{
    "clinical_study": {
        "@rank": "79035", 
        "arm_group": {
            "arm_group_label": "Oral Nutritional Supplement (ONS)", 
            "arm_group_type": "Experimental", 
            "description": "1-2 serving per day of a renal specific oral nutritional supplement"
        }, 
        "brief_summary": {
            "textblock": "The study objective is to evaluate if a renal specific oral nutrition supplement (ONS) aids\n      in maintaining nutritional status."
        }, 
        "brief_title": "The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Kidney Disease", 
        "condition_browse": {
            "mesh_term": [
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. >18 years of age\n\n          2. Diagnosed with Chronic Kidney Disease (CKD); Stages 3b to 5\n\n          3. eGFR \u2264 45 and \u2265 10 ml/min/1.73m2\n\n          4. Male or non-pregnant female at least six weeks postpartum and non-lactating\n\n          5. Subject with CKD is either: not diagnosed with Type 2 Diabetes Mellitus (T2DM) OR\n             diagnosed with T2DM and had no changes in glycemic medication (dose or type) for at\n             least 2 months\n\n          6. Serum albumin \u2265 3.0g/dl\n\n          7. BMI \u2264 27 kg/m2\n\n          8. If T2DM, subject has A1c level \u2264 9.0%\n\n          9. Not scheduled or expected to receive dialysis in the next 18 months\n\n         10. Life expectancy >18 months\n\n        Exclusion Criteria:\n\n          1. Type 1 diabetes\n\n          2. Subjective Global Assessment = 1 to 3\n\n          3. Intravenous albumin treatment within the last 6 months.\n\n          4. Overt symptomatic peripheral neuropathy, retinopathy, or autonomic neuropathy.\n\n          5. Poorly controlled chronic hypertension >200/100 or hypotension <90/60 defined by The\n             Joint National Committee 7 (JNC 7).\n\n          6. Major surgery, inpatient or outpatient, requiring >7 days of hospitalization in the\n             last 3 weeks prior to screening visit, or is having major elective surgery requiring\n             >7 days of hospitalization throughout the course of the entire study.\n\n          7. Chronic/contagious infectious disease, clotting or bleeding disorder, active\n             malignancy or impaired liver function\n\n          8. Missing, or has had an amputation of, a limb.\n\n          9. Significant cardiovascular event  \u2264 6 months; or stated history of congestive heart\n             failure\n\n         10. Obstruction of the gastrointestinal tract, inflammatory bowel disease, short bowel\n             syndrome or other forms of gastrointestinal disease such as gastroparesis,\n             pancreatitis, hepatitis, jaundice, celiac disease, intestinal dysmotility and\n             ischemic colitis.\n\n         11. Current diagnosis or history of severe dementia or delirium, eating disorder, history\n             of significant neurological or psychiatric disorder, alcoholism, substance abuse\n\n         12. Medications/dietary supplements/herbals or substances that could modulate glucose\n             metabolism, or are considered anabolic, or can reduce fat mass, including but not\n             limited to protein/amino acid supplements, or modified amino acid supplements such as\n             keto acids, growth hormone, dronabinol, marijuana, calcium\n             beta-hydroxyl-beta-methylbutyrate, high dose fish oil supplements (>0.5 g omega-3/d)\n             or vitamin D (>400IU/d),\n\n         13. Allergic or intolerant to any ingredient found in the study product."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "124", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02046746", 
            "org_study_id": "DA03"
        }, 
        "intervention": {
            "arm_group_label": "Oral Nutritional Supplement (ONS)", 
            "description": "renal specific commercially available ONS", 
            "intervention_name": "Oral Nutritional Supplement (ONS)", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 24, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Kaohsiung City", 
                    "country": "Taiwan", 
                    "zip": "80708"
                }, 
                "name": "Kaohsiung Medical University Hospital (KMUH)"
            }, 
            "investigator": {
                "last_name": "Shang-Jyh Hwang, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status and Other Outcomes", 
        "overall_contact": {
            "email": "kristen.deluca@abbott.com", 
            "last_name": "Kristen DeLuca, MS, RD", 
            "phone": "614-624-5455"
        }, 
        "overall_contact_backup": {
            "email": "bobbie.swearengin@abbott.com", 
            "last_name": "Bobbie Swearengin, RN", 
            "phone": "614-624-7182"
        }, 
        "overall_official": {
            "affiliation": "Abbott Nutrition", 
            "last_name": "Owen Kelly, Ph.D", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Serum Albumin", 
            "safety_issue": "No", 
            "time_frame": "Change from Month 0 to Month 6"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02046746"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Subjective Global Assessment", 
                "safety_issue": "No", 
                "time_frame": "Change from Month 0 to Month 6"
            }, 
            {
                "measure": "Dietary Intake Compliance", 
                "safety_issue": "No", 
                "time_frame": "Change from Month 0 to Month 6"
            }, 
            {
                "measure": "Hand Grip Strength", 
                "safety_issue": "No", 
                "time_frame": "Change from Month 0 to Month 6"
            }, 
            {
                "measure": "Appetite", 
                "safety_issue": "No", 
                "time_frame": "Change from Month 0 to Month 6"
            }, 
            {
                "measure": "Body Mass Index", 
                "safety_issue": "No", 
                "time_frame": "Change from Month 0 to Month 6"
            }, 
            {
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "Change from Month 0 to Month 6"
            }
        ], 
        "source": "Abbott Nutrition", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott Nutrition", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}